A consensus guideline of herbal medicine for coronavirus disease 2019
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCISCIEScopus
- 저널 순위
- JCR Q2
- 저널
- Integrative Medicine Research9(3) · 2020
- 피인용
- Web of Science 21Scopus 22KCI 7
- FWCI (Scopus)
- 0
- JCR IF
- JCR 2019 2.172
- ISSN
- 2213-4220
저자
- Lee, Beom-Joon제1저자Division of Allergy, Immune and Respiratory System, Department of Internal Medicine, College of Korean Medicine, Kyung Hee University Seoul, Republic of Korea
- Lee, Ju AhHwapyeong institute of integrative medicine, Incheon, Republic of Koreac
- Kim, Kwan-IlDivision of Allergy, Immune and Respiratory System, Department of Internal Medicine, College of Korean Medicine, Kyung Hee University Seoul, Republic of Korea
- 최준용교신저자cKorean Medicine Hospital of Pusan National University, Gyeongsangnam-do, Republic of Korea
- Jung, Hee-Jae교신저자Division of Allergy, Immune and Respiratory System, Department of Internal Medicine, College of Korean Medicine, Kyung Hee University Seoul, Republic of Korea
초록
Background: The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2), which originated in Wuhan, Hubei Province, China in late December 2019, is the cause of ongoing pandemic. We analyzed the symptoms of SARS-CoV-2, a classification of the Chinese medicine dialectic and treatment regimen, and promptly enacted the recommendation of Korean medicine preparations in herbal medicine covered under domestic medical insurance benefits depending on the circumstances in our country. Method: The clinical practice guideline (CPG) for the treatment of SARS-CoV-2 was developed based on consensus from a group of experts. Results: Two kinds of herbal medicines (HM) were recommended for the prevention of SARS-CoV2; Youngyopaedoc-san plus Bojungikgitang, and Youngyopaedoc-san plus Saengmaek-san. Two herbal preparations were recommended for people with a history of exposure to SARS-CoV-2; Youngyopaedocsan plus Bulhwangeumjeonggi-san, and Youngyopaedoc-san plus Bojungikgi-tang. Three herbal preparations were recommended for mildly symptomatic COVID-19 patients; Youngyopaedoc-san plus Galgunhaegui-tang was recommended for those without pneumonia with wind-warmth disease invading the lungs; Sosiho-tang plus Bulhwangeumjeonggi-san was recommended for those with dampness-heat disease in the lungs. For the recovery stage, Samchulkunbi-tang plus Saengmaek-san, or Samchulkunbitang plus Chungseuiki-tang was recommended. Conclusion: The CPG was developed to guide the use of Korean herbal medicine in the treatment of SARSCoV-2, and it is expected that this will be the basis for providing proper treatment of similar infectious diseases in the future. (c) 2020 Korea Institute of Oriental Medicine. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
키워드
SARS-CoV-2Clinical practice guidelineKorean medicineHerbal medicine
식별자
- Scopus EID
- 2-s2.0-85091738491
- WoS UID
- 000571582500006
- KCI
- ART002626110



로그인
연구물 목록으로